{
Agilent Technologies, Inc.

Companies

}
001122334455554433221100
001122334455554433221100

global clinical biomarkers market projected to reach 47 billion by 2031

The global clinical biomarkers market, valued at $25.02 billion in 2023, is projected to reach $47.25 billion by 2031, growing at a CAGR of 8.54%. This growth is driven by rising cancer cases and advancements in diagnostic technologies, despite challenges like high costs and reimbursement issues. Key players include Roche, Abbott, and Johnson & Johnson, with significant developments in biomarker testing for various diseases.
openPR.com
Eurofins Scientific S.E. A PerkinElmer Inc Johnson & Johnson Services Inc. Bio-Rad Laboratories, Inc. Qiagen N.V. Merck KGaA Thermo Fisher Scientific Inc. General Electric Co Siemens Healthineers AG Agilent Technologies, Inc. F. Hoffmann-La Roche Ltd. USA Show more
Healthcare, Market Report
08:45 16.12.2024

healthcare automation market projected to reach 112.95 billion by 2028

The healthcare automation market is projected to grow from $64.93 billion in 2023 to $112.95 billion by 2028, with a CAGR of 11.9%. Key growth drivers include regulatory compliance, patient safety, and the adoption of advanced technologies like AI and robotics. North America currently holds the largest market share.
EIN News
United States Dollar Stryker Corporation Abbott Laboratories Medtronic plc Allscripts Healthcare Solutions Inc Cerner Corporation Cigna Corporation 3M Company Aetna Inc. Agilent Technologies, Inc. Becton Co. International Business Machines Corporation Oracle Corporation Danaher Corporation Dickinson and Company OptumHealth General Electric Company UnitedHealth Group Incorporated GBR Show more
Healthcare, Market Report
19:30 03.12.2024

agilent technologies announces dividend increase and market performance update

Agilent Technologies has a market cap of $39.65 billion and recently increased its quarterly dividend to $0.248 per share, reflecting a 0.72% yield. The company operates in life sciences and diagnostics, with a "Hold" rating from analysts and a price target averaging $143.40. Institutional investors have been actively acquiring shares, indicating ongoing interest in the stock.
MarketBeat
Agilent Technologies, Inc. USA Dominique Grau
TradFi, Market Report
11:21 30.11.2024

nebulizers market growth analysis and competitive landscape insights for 2024 to 2031

The global Nebulizers market is projected to grow from USD 944.4 million in 2022 to USD 1,634.0 million by 2030, with a CAGR of 7.2% from 2024 to 2031. Key players include Vyaire Medical, Koninklijke Philips N.V, and OMRON Healthcare, focusing on innovations and strategic partnerships to enhance market presence. The report provides a comprehensive analysis of market segments, regional dynamics, and competitive strategies shaping the industry landscape.
openPR.com
United States Dollar OMRON Healthcare Inc Microlife Corporation Koninklijke Philips N.V. Beurer GmbH Agilent Technologies, Inc. Aerogen Drive DeVilbiss Healthcare Vyaire Medical Inc. Allied Healthcare Products, Inc. PARI Respiratory Equipment, Inc Vyaire Medical PARI Respiratory Equipment Drive DeVilbiss Healthcare Koninklijke Philips N.V Allied Healthcare Show more
Healthcare, Market Report
22:45 15.11.2024

global healthcare services market poised for significant growth through 2028

The global healthcare services market is projected to grow from $8,348.44 billion in 2023 to $8,963.64 billion in 2024, driven by advancements in medical technology, an aging population, and health insurance expansion. By 2028, it is expected to reach $10,908.99 billion, with key trends including telemedicine integration and patient-centered care. Shared medical appointments are gaining traction as a cost-effective model for managing chronic conditions, enhancing patient outcomes through collaborative care.
openPR.com
United States Dollar Community Health Systems, Inc. UnitedHealth Group Incorporated CVS Health Corporation Regeneron Pharmaceuticals, Inc. Cardinal Health, Inc. Fresenius Medical Care AG & Co. KGaA Centene Corporation Baxter International Inc. Mayo Clinic Agilent Technologies, Inc. Johnson & Johnson Pfizer Inc. Cleveland Clinic Global Solutions LLC McKesson Corporation Merck & Co., Inc. Abbott Laboratories Bristol-Myers Squibb Company Quest Diagnostics Incorporated HCA Healthcare, Inc. Gilead Sciences, Inc. Kaiser Permanente Group Trust Cigna Corporation Stryker Corporation Tenet Healthcare Corporation Danaher Corporation AbbVie Inc. Boston Scientific Corporation Molina Healthcare, Inc. Align Technology, Inc. AmerisourceBergen Corporation Laboratory Corporation OF America Holdings DaVita Inc. Eli Lilly and Company Humana Inc. West Pharmaceutical Services, Inc. Fresenius Medical Care AG & Co. KGaA Kaiser Permanente UnitedHealth Group Incorporated Tenet Healthcare HCA Healthcare Show more
Healthcare, Market Report
20:40 11.11.2024

growth and challenges in the global nano-sensor market

The global nano-sensor market is experiencing significant growth, projected to reach $2.37 billion to $3.1 billion by 2032, driven by demand in healthcare, environmental monitoring, and industrial applications. Key advancements include eco-friendly pH-responsive sensors and the integration of AI for material selection, despite challenges in manufacturing and sensor stability. North America leads in research and development, while Europe focuses on sustainable nano-sensor innovations.
AZoNano
United States Dollar Agilent Technologies, Inc. USA
Technology & Innovation, Market Report
09:00 07.10.2024

healthcare etfs offer growth potential and defensive investment strategies

Investing in healthcare ETFs offers Canadian investors a way to diversify their portfolios, which are often underweight in this sector. Despite its volatility, the healthcare sector is expected to see growth driven by an aging population, technological advancements, and increased healthcare spending. Funds like the Hamilton Healthcare Yield Maximizer ETF and Harvest Healthcare Leaders Income ETF utilize covered call strategies to enhance yields, appealing to those seeking defensive investments with growth potential.
Finance et Investissement
Eli Lilly and Company Intuitive Surgical, Inc. UnitedHealth Group Incorporated Novo Nordisk A/S Amgen Inc. Thermo Fisher Scientific Inc. Zoetis Inc. Pfizer Inc. Merck & Co., Inc. Agilent Technologies, Inc. Stryker Corporation Johnson & Johnson CAN USA Chris Cullen Novo Nordisk A/S Mike Clare Paul MacDonald Nick Piquard Show more
Finance & Economy, Market Report
09:00 03.10.2024
Trending
Subcategory
Corporate News Industry Trends Stock Market Updates Retail and Consumer Goods Startups & Entrepreneurship CEO Changes Financial Scams and Security Banking Regulations Global Financial Events Finance Mergers & Acquisitions Market Analysis and Predictions Industry Mergers & Acquisitions Central Bank Actions Hedge Funds & Private Equity Workplace Trends Global Trade Developments Supply Chain Management Government Economic Policies Corporate Social Responsibility AI Innovations
Countries:
USA CHN IND GBR JPN CHE SGP ARE QAT IDN SAU DEU MYS KOR CAN KWT VNM THA ISR NLD
Companies:
Wells Fargo & Company The Goldman Sachs Group, Inc. Tesla, Inc. Barclays PLC Bank of America Corporation NatWest Group plc Apple Inc. JPMorgan Chase & Co. Lloyds Banking Group plc Mastercard Inc Visa Inc. Santander UK plc Morgan Stanley Mercedes-Benz Group AG Amazon.com, Inc. OpenAI ERC USD Tiktok USD DoorDash, Inc. Deliveroo plc Nissan Motor Co., Ltd.
Currencies:
United States Dollar Chinese Yuan British Pound Sterling Euro Swiss Franc Japanese Yen Indonesian Rupiah Indian Rupee Offshore Chinese Yuan United Arab Emirates Dirham Singapore Dollar Qatari Riyal South Korean Won Jordanian Dinar Brazilian Real
People:
Donald Trump Elon Musk Rachel Reeves Warren Buffett Jamie Dimon Charlie Nunn Georges Elhedery Mike Regnier Paul Thwaite Hidenori Tanaka Andrew Bailey Joe Biden Jean Du Boullay Raoul Pal Rosan Roeslani Prabowo Subianto Moeldoko Patrick P. Gelsinger Michael Beckerman Mu Qing

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.